This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Nov. 27, 2012 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the quarter and fiscal year ended
September 30, 2012 on
Tuesday, December 4, 2012 at
11:00 a.m. Eastern Time (EST). The Company expects to report its operating results earlier the same day.
Shareholders and other interested parties may participate in the conference call by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and asking to be connected to "The Female Health Company Conference Call" a few minutes before 11:00 a.m. EST on December 4, 2012. A replay of the call will be available one hour after the call through 9:00 a.m. EST on Tuesday, December 18, 2012 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 10021755. About The Female Health Company
The Female Health Company, based in
Chicago, Illinois, manufactures and markets
the FC2 Female Condom® (FC2), which is available in the U.S. and approximately 138 other countries globally. The Company owns certain worldwide rights to the
FC2 Female Condom®, including patents that have been issued by the U.S., the European
The People's Republic of China,
Turkey and the African Regional Intellectual Property Organization (ARIPO), which includes
Uganda, United Republic of
Zambia and Zimbabwe.
FC2 patent applications are pending in various countries. The
FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared
FC2 for purchase by U.N. agencies.